1. Home
  2. XLO vs AMPG Comparison

XLO vs AMPG Comparison

Compare XLO & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • AMPG
  • Stock Information
  • Founded
  • XLO 2016
  • AMPG 2002
  • Country
  • XLO United States
  • AMPG United States
  • Employees
  • XLO N/A
  • AMPG N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • AMPG Telecommunications Equipment
  • Sector
  • XLO Health Care
  • AMPG Telecommunications
  • Exchange
  • XLO Nasdaq
  • AMPG Nasdaq
  • Market Cap
  • XLO 37.9M
  • AMPG 29.1M
  • IPO Year
  • XLO 2021
  • AMPG N/A
  • Fundamental
  • Price
  • XLO $0.75
  • AMPG $1.54
  • Analyst Decision
  • XLO Buy
  • AMPG Strong Buy
  • Analyst Count
  • XLO 1
  • AMPG 1
  • Target Price
  • XLO $4.00
  • AMPG $5.00
  • AVG Volume (30 Days)
  • XLO 233.1K
  • AMPG 347.9K
  • Earning Date
  • XLO 05-13-2025
  • AMPG 05-27-2025
  • Dividend Yield
  • XLO N/A
  • AMPG N/A
  • EPS Growth
  • XLO N/A
  • AMPG N/A
  • EPS
  • XLO N/A
  • AMPG N/A
  • Revenue
  • XLO $6,344,000.00
  • AMPG $9,508,372.00
  • Revenue This Year
  • XLO $668.96
  • AMPG $82.37
  • Revenue Next Year
  • XLO $14.49
  • AMPG $76.47
  • P/E Ratio
  • XLO N/A
  • AMPG N/A
  • Revenue Growth
  • XLO N/A
  • AMPG N/A
  • 52 Week Low
  • XLO $0.62
  • AMPG $0.64
  • 52 Week High
  • XLO $1.70
  • AMPG $6.43
  • Technical
  • Relative Strength Index (RSI)
  • XLO 50.38
  • AMPG 50.67
  • Support Level
  • XLO $0.63
  • AMPG $1.30
  • Resistance Level
  • XLO $0.80
  • AMPG $1.75
  • Average True Range (ATR)
  • XLO 0.06
  • AMPG 0.15
  • MACD
  • XLO 0.01
  • AMPG 0.03
  • Stochastic Oscillator
  • XLO 72.71
  • AMPG 61.11

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: